Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
PUT
FedEx
FDX
$74.7B
| $23M | 0.01% |
97,500
-12,600
| -11% | -$2.9M |
|
|
TLN
1152
CALL
Talen Energy Corp
TLN
$16.2B
| $23M | 0.01% |
+54,000
| New | +$19.5M |
|
1153
iShares Russell 1000 Growth ETF
IWF
$127B
| $23M | 0.01% |
196,140
+100,040
| +104% | +$11.1M |
|
1154
Old National Bancorp
ONB
$10.2B
| $23M | 0.01% |
1,045,680
-10,270
| -1% | -$227K |
|
1155
Cirrus Logic
CRUS
$6.19B
| $22.9M | 0.01% |
183,122
+128,362
| +234% | +$14.3M |
|
1156
Valley National Bancorp
VLY
$8B
| $22.9M | 0.01% |
2,164,159
+694,459
| +47% | +$6.94M |
|
1157
Paycom
PAYC
$10.1B
| $22.9M | 0.01% |
110,191
-3,596
| -3% | -$810K |
|
1158
New Oriental
EDU
$9.04B
| $22.9M | 0.01% |
431,564
+220,129
| +104% | +$10.9M |
|
1159
Madrigal Pharmaceuticals
MDGL
$11.8B
| $22.9M | 0.01% |
49,912
-12,762
| -20% | -$4.76M |
|
1160
PUT
AbbVie
ABBV
$431B
| $22.9M | 0.01% |
98,800
-16,000
| -14% | -$3.26M |
|
1161
Baidu
BIDU
$37.1B
| $22.9M | 0.01% |
173,534
+92,518
| +114% | +$9.16M |
|
1162
CALL
Intercontinental Exchange
ICE
$84.1B
| $22.8M | 0.01% |
+135,600
| New | +$24.2M |
|
1163
PUT
RTX Corp
RTX
$301B
| $22.8M | ﹤0.01% |
136,300
+27,200
| +25% | +$4.22M |
|
1164
Pool Corp
POOL
$7.31B
| $22.8M | ﹤0.01% |
73,532
-19,802
| -21% | -$6.21M |
|
1165
CALL
GameStop
GME
$8.63B
| $22.8M | ﹤0.01% |
835,500
+690,500
| +476% | +$16.4M |
|
1166
Freshpet
FRPT
$3.21B
| $22.8M | ﹤0.01% |
413,573
+208,961
| +102% | +$12.9M |
|
1167
CRISPR Therapeutics
CRSP
$4.99B
| $22.7M | ﹤0.01% |
349,851
-30,772
| -8% | -$1.77M |
|
1168
Transmedics
TMDX
$2.78B
| $22.6M | ﹤0.01% |
201,858
+16,434
| +9% | +$1.92M |
|
1169
Progress Software
PRGS
$1.71B
| $22.6M | ﹤0.01% |
514,999
-59,723
| -10% | -$2.75M |
|
1170
CALL
Berkshire Hathaway Class B
BRK.B
$1.13T
| $22.6M | ﹤0.01% |
45,000
+10,000
| +29% | +$4.84M |
|
|
1171
PUT
Berkshire Hathaway Class B
BRK.B
$1.13T
| $22.6M | ﹤0.01% |
45,000
+10,000
| +29% | +$4.84M |
|
|
GAP
1172
CALL
The Gap Inc
GAP
$7.39B
| $22.6M | ﹤0.01% |
1,057,600
-720,900
| -41% | -$15.6M |
|
1173
Halozyme
HALO
$10.2B
| $22.6M | ﹤0.01% |
308,223
+12,688
| +4% | +$843K |
|
1174
PUT
Enphase Energy
ENPH
$5.24B
| $22.5M | ﹤0.01% |
636,000
-1,280,000
| -67% | -$47.6M |
|
1175
Watsco Inc
WSO
$13.2B
| $22.5M | ﹤0.01% |
55,665
-139,459
| -71% | -$59.6M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.